Compare Dolby Laboratories, Inc. (DLB) vs Kenvue Inc. Common Stock (KVUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Kenvue Inc. Common Stock — how do they compare? Dolby Laboratories, Inc. trades at $58.74 (market cap $5.47B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 6.2× Dolby Laboratories, Inc.'s market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| DLB | KVUE | |
|---|---|---|
Market Cap | $5.47B | $34.06B |
Volume | 1,058,284 | 23,267,228 |
Sector | Technology | Consumer Staples |
52-Week High | $70.09 | $19.83 |
52-Week Low | $48.51 | $14.11 |
Typical Hold Time | 98 Days | — |
Enterprise Value | $4.85B | $41.56B |
Dividend Yield | 2.46% | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DLB trades at $58.45, up 0.17% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with a P/E of 24.87 and net income margin of 16.7%. Recent news highlights expansion of Dolby Atmos and Vision with Meta, and a leadership transition to Marc Whitten.
DLB's outlook is supported by analyst consensus with a $90.33 price target and 47% buy ratings, but faces risks from licensing volatility and projected earnings decline. The stock offers growth potential through digital content expansion, yet investors should weigh near-term execution challenges against long-term format adoption.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →
